I don't thinks its shorts and I don't think its Na

I don't thinks its shorts and I don't think its Nader. Its frustration from investors from always being so close and then being told we need more data, even though renowned Dr s keep shouting our praise. If we don't get approval for mm next week, we will have to wait 2 or 3 months for another opportunity. Who is going to prop or SP up during that span. Im tapped just like 80% of the other die hard longs. This next week is extremely important and I think a lot of investors are preparing for the worst case scenario, more testing for data, by taking out cash in case SP slips. All these other bio companies are soaring and were stagnant or reversing, even though we are the answer. Its frustrating and I hope we get approval or EUA next week.